In just a matter of weeks since the inauguration of Donald Trump as the 47th president of the United States of America (US), he has already signed multiple executive orders, some of which could have a significant impact, not just on the US tax landscape, but on global tax policy.

Of course, many of Trump’s policy objectives were well documented through the presidential campaign, although tax policy certainly took a back seat this time around when compared to the issues debated in the run up to the 2016 US election, when Trump first took the Oval Office.

12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.

The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand Interaction Fingerprints (PLIF).

Science, research and innovation are core disciplines that will undoubtedly help the human race address many of the key challenges it faces. Whether it is dealing with climate change, ending world hunger or living healthier and longer lives, we need to create environments that will enable scientists and researchers to make ground-breaking discoveries to be made. That means building a support network to work alongside them made up of individuals with other skills and disciplines.

PrecisionLife has been awarded a €2.5m non-dilutive grant by the European Innovation Council (EIC) for its TRANSCEND project, to more rapidly and accurately triage and treat patients with endometriosis. The project is based on PrecisionLife’s unique insights into the biological mechanisms underpinning this complex chronic disease. It will develop and clinically validate a rapid and non-invasive precision medicine test to evaluate a patient’s risk of endometriosis and the mechanisms underpinning their disease.